Director of the Breast Center and Head of the Oncological Therapy and Clinical Trials Unit and the Center for Hereditary Breast and Ovarian Cancer at the Department of Obstetrics and Gynecology, LMU University Hospital, Munich. She also holds the Chair of Conservative Oncology and is a Steering Committee Member of CCC Munich LMU.​

Prof. Nadia Harbeck has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Daiichi-Sankyo, Gilead, Lilly, MSD, Novartis, Pierre-Fabre, Pfizer, Roche, Sandoz, Stemline-Menarini, Viatris.

Other: Co-Director West German Study Group.